The adventures of the clinical trial for CGVHD continue! #gvhd #cancersurvivor | Surf
1:05
The adventures of the clinical trial for CGVHD continue! #gvhd #cancersurvivor | Surf
30.1K views7 months ago
FacebookSurf
Foundations of cGVHD Diagnosis and Severity Assessment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Foundations of cGVHD Diagnosis and Severity Assessment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
3 months ago
targetedonc.com
Overview of Advanced Therapies in cGVHD | OncLive
6:21
Overview of Advanced Therapies in cGVHD | OncLive
Sep 12, 2024
onclive.com
See why it is so important to watch for symptoms of chronic graft-versus-host disease (cGVHD) and to talk to a healthcare provider right away. https://qrcodes.incyte.com/1BVRcP INDICATIONS AND SELECTED SAFETY INFORMATION Jakafi® (ruxolitinib) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (GVHD) who have taken one or two types of treatments and they did not work well enough. Jakafi can cause serious side effects inclu
0:47
See why it is so important to watch for symptoms of chronic graft-versus-host disease (cGVHD) and to talk to a healthcare provider right away. https://qrcodes.incyte.com/1BVRcP INDICATIONS AND SELECTED SAFETY INFORMATION Jakafi® (ruxolitinib) is a prescription medicine used to treat adults and children 12 years of age and older with chronic graft-versus-host disease (GVHD) who have taken one or two types of treatments and they did not work well enough. Jakafi can cause serious side effects inclu
1M views7 months ago
FacebookJakafi (ruxolitinib)
Targeting cGVHD: Mechanism of Action of Axatilimab Compared to Other Available Agents
Targeting cGVHD: Mechanism of Action of Axatilimab Compared to Other Available Agents
96 viewsOct 14, 2024
vumedi.com
Understanding cGVHD: From Diagnosis to Initial Therapies | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Understanding cGVHD: From Diagnosis to Initial Therapies | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
May 15, 2025
targetedonc.com
Sequencing in the cGVHD Treatment Paradigm | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Sequencing in the cGVHD Treatment Paradigm | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
4 months ago
targetedonc.com
1:26
📌 La GVHD chronique (cGVHD) ou maladie du greffon contre l’hôte, survient après une greffe de moelle osseuse, lorsque les cellules du donneur attaquent le corps du receveur. 💡 Afin de mettre en lumière les implications psychologiques et l’impact sur l'image de soi de la cGHVD, Sanofi en France a organisé la masterclass #cGVHDLoveYourself, réunissant patients, aidants, professionnels de santé et associations. 🎥 Découvrez-en davantage dans cette vidéo avec le Dr Anne Huynh, hématologue, Laure V
68.6K viewsJan 21, 2025
FacebookWe Are Patients
Dr. Chen on Risk Factors for Developing cGVHD | OncLive
Dec 1, 2021
onclive.com
8:18
Mechanisms of action of ibrutinib, ruxolitinib, and belumosudil, and their role in cGvHD treatment
691 viewsMar 25, 2022
gvhdhub.com
Scenario 2: Belumosudil and Axatilimab as Treatment Options in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Apr 4, 2022
targetedonc.com
1:30
Journée mondiale de la cGVHD : ensemble, pour soutenir les patients 💜 La GVH chronique (cGVHD) ou maladie du greffon contre l’hôte, survient après une greffe de moelle osseuse, lorsque les cellules du donneur attaquent le corps du receveur. 🎥 À l’occasion de cette journée dédiée, mettons en lumière le rôle essentiel des associations dans la prise en charge et l’accompagnement des patients dans cette vidéo en collaboration avec Sanofi en France. 💬 Guy Bouguet, président de ELLyE - Ensemble Leu
44K viewsJan 21, 2025
FacebookWe Are Patients
1:11
Dr Lee on 3-Year Follow-Up Data From the ROCKstar Trial of Belumosudil in cGVHD | OncLive
Feb 23, 2024
onclive.com
3:22
What are the first symptoms of scleroderma?
9.5K viewsJun 21, 2019
YouTubeWeAreSRUK
The ROCKstar Study of Belumosudil in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Aug 23, 2023
targetedonc.com
1:28
Symposium | Quality of life and symptoms in cGvHD
55 views5 months ago
YouTubeGvHD Hub
cGVHD Updates: Steroid Refractory/Dependent Disease, Assessment, 2L/3L Options, New Treatments in Pipeline
5 months ago
vumedi.com
16:56
Advancing to Third-Line Therapy: Belumosudil in cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Sep 24, 2024
targetedonc.com
1:35
Dr. Schroeder on Treatment Options for GVHD
64 viewsFeb 28, 2020
YouTubeOncLive
0:52
l Tools 🥰 for Tech Enthusiasts #shorts #shortsfeed #viralshorts
2.6K views1 month ago
YouTubeJafar Jafar
48:25
Blum Center Program: Scleroderma - Symptoms, Diagnosis, and Treatments
801 viewsJun 5, 2024
YouTubeMassGeneralHospital
FDA Approvals of Systemic Therapy for Steroid-Refractory cGVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1 year ago
targetedonc.com
12:31
SCLERODERMA SYMPTOMS, PATHOPHYSIOLOGY, TYPES, & COMPLICATIONS
6.2K viewsJan 17, 2022
YouTubeScholarly Nurse
5:37
An Overview of Scleroderma Part 2: Treatment and management
43.7K viewsDec 8, 2015
YouTubeDemystifying Medicine McMaster
2:54
How to Change Your Blaze Grill's Fuel Type - Blazegrills.com
19.8K viewsDec 9, 2013
YouTubeBlaze Grills
0:15
😡🔥MBAPPÉ NÃO TOCA BOLA! TRETA: NEYMAR vs MBAPPÉ! #shorts
141.8K viewsAug 14, 2022
YouTubeCOIMBRA- Futebol
41:03
Madrastra intentaba mandar CIELO a su HIJASTRA sin pensar que pasaría esto
30.2K viewsFeb 25, 2025
YouTubeNathalya
1:09
MLG cGVHD Update Dec 2025 Transplant Dr A 1_Final_1_2DCENT
4 months ago
VimeoCenter City Film & Video
Automatic analysis of 3D skin images for chronic graft-versus-host disease (cGVHD) severity assessment
Oct 31, 2011
vanderbilt.edu
1:22:00
Rising to the GVHD Challenge
39 views4 months ago
YouTubePeerView Oncology
See more
Static thumbnail place holder